Diabetes Care 41 , 613619 (2018)
Quick look at the key results According to clinical trial investigators, orforglipron: Led to significant weight reduction across all dosing groups Showed greater effects at the highest dose levels Helped lower blood sugar in people with diabetes Supported modest improvements in blood pressure Demonstrated mainly mild to moderate side effects The trial results suggest that the once-daily pill performs competitively with early GLP-1 injection studies
Critical adjustment period Early months require guidance for dosing, tolerance, & progress for long-term success 2x Longer on therapy Ongoing support keeps patients on GLP-1s 2x longer, maximizing long-term benefits 9+ Systems affected GLP-1s influence brain, heart, kidney, & more
The GI effects of retatrutide, particularly nausea and reduced appetite, can make it harder to maintain the caloric and protein intake needed to support tissue repair processes
How to Know Your Protocol is Working Weight on the scale is the most obvious metric, but it is not the only one and it is not always the most reliable week to week
Ordering as easy as 1, 2, 3 1
